Alzey
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
US pharma giant is unhappy with Germany; CEO calls planned healthcare reform ‘terrible’
US pharmaceutical giant Eli Lilly has announced that it is halving its massive €2.3 billion ($2.67 billion) investment plan to build a high-tech manufacturing plant in Alzey, Rhineland-Palatinate in what can be seen a major blow to Germany’s industrial ambitions. The rollback targets a facility originally designed to be one of Eli Lilly’s largest and most modern factories worldwide, intended to produce its highly sought-after weight-loss and diabetes injection, Mounjaro. Eli Lilly CEO Dave...